We are thrilled to announce that Botanic Pretti5 (“Pretti5”), one of our valued clients at ELLALAN, has successfully secured a significant seed investment deal from FRO Management Limited (“FRO”), a multi-family office based in Hong Kong renowned for managing alternative private assets across Hong Kong, Greater China, Southeast Asia, North Asia, and the US.

Pretti5 is a Traditional Chinese Medicine (“TCM”) – infused, clean and adaptogenic skincare solution suitable for all skin types, especially designed for sensitive skin, to restore natural healthy glow. With a focus on consumer, healthcare, and tech sectors, FRO’s venture capital investment philosophy align perfectly with Pretti5. This equity round will fuel Pretti5’s business expansion and pave the way for broader geographical reach to Singapore, Japan and the United States. Without the oriental herbal foundations, remarkable R&D and sustainability vision of Pretti5 to innovate TCM into highly effective topical skincare products, this deal’s success would not have been possible. We are immensely proud to partner with such a forward-thinking company.

At ELLALAN, we are dedicated to empowering our clients and partnering with them to achieve their goals. It has been our privilege to support Pretti5 throughout their journey, and we are honored to have played a crucial role in securing this game-changing investment.

Congratulations to Pretti5 on this well-deserved success! We are confident that Pretti5 is going to reach a new height of success.